¿¼²©±¨°à ¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ÿÈÕÇ©µ½
Ö÷Ìâ : µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©
¼¶±ð: ²©Ê¿
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-20   

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£©

µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© /._wXH  
C,w$)x5kls  
  Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© \HDRr*KO  
  1¡¢Co-stimulators (or co-stimulating molecules) Frt_X%  
  2¡¢NK-kB PCs+` WP!M  
  3¡¢Immunoglobulin superfamily #nc{MR#R  
  4¡¢antigen-presenting cell (APC) n-dO |3,  
  5¡¢death domain S5'BXE,  
  6¡¢CCR and CXCR 5isejR{r  
  7¡¢Lectin (or mitogen) Z-b^{uP  
  8¡¢Clusters of differentiation, CD) _EOQ*K#=Ct  
  9¡¢B7 family @7%nMTZ@&v  
  10¡¢Cytotoxic T lymphocyte, CTL) s} ,p>8  
  11¡¢IL-15 and IL-15 receptor (IL-15R) Vu FH >8n  
  12¡¢MHC restriction r9G<HKl  
  13¡¢Affinity-chromatography g!<@6\RB  
  14¡¢Cyctosprin A, CsA LZy Ulz  
  15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) A%u-6"  
5-bd1 !o  
  ¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 9S.Uo[YY  
  1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 }@}jwi)l  
  2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ A[Juv]X  
  3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌص㡣 u Y/Q]N T  
8(D>ws$  
  Èý¡¢ÎÊ´ðÌ⣨25·Ö£© u A:|#mO  
  1¡¢Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ c0u!V+V%  
  ѪҺ²¡Ñ§×¨Òµ£º $\$5::}r  
  2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
Ãâ·Ñ¿¼²©ÍøÍøÖ·ÊÇʲô? ÕýÈ·´ð°¸:freekaobo.com
°´"Ctrl+Enter"Ö±½ÓÌá½»